Essential Partners
MIRM icon

Essential Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Essential Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$427 Hold
5
– – ﹤0.01% 2441
2026
Q2 		$585 Hold
5
– – ﹤0.01% 2436
2026
Q1 		$462 Hold
5
– – ﹤0.01% 2459
2025
Q4 		$395 Sell
5
-2
-29% -$144 ﹤0.01% 2283
2025
Q3 		$513 Buy
7
+2
+40% +$127 ﹤0.01% 2199
2025
Q2 		$254 Buy
+5
New +$223 ﹤0.01% 1891

Other funds holding MIRM

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Secure Asset Management
Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Contravisory Investment Management
Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
WIA
Wetzel Investment Advisors Indianapolis, Indiana $290M AUM 16.64% 1-Year Est. Return

Essential Partners's MIRM Position: Q3 2026 in Review

Essential Partners held its Mirum Pharmaceuticals (MIRM) position steady in Q3 2026 at 5 shares worth $427. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

Essential Partners first reported a position in MIRM in Q2 2025 and has held it in 6 quarters since. The position peaked at $585 in Q2 2026. 33 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Essential Partners held 5 shares of Mirum Pharmaceuticals worth $427 as of Q3 2026.
  • Essential Partners left its Mirum Pharmaceuticals share count unchanged in Q3 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2441 holding.
  • Essential Partners first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Mirum Pharmaceuticals position peaked at $585 in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.